Case law is helping shape how to distinguish deductible legal fees associated with patent infringement lawsuits from capitalizable fees associated with obtaining the right to enter the market for generic drugs from the U.S. Food and Drug Administration (FDA). Given the potential tax impact, it’s important to ensure that legal and service provider fees are properly documented and categorized.

Download Whitepaper